Needham Reiterates Buy on OrthoPediatrics
The reiterated Buy rating and sizable gap to the stated target are bullish, though analyst targets are opinions and do not guarantee performance.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The reiterated Buy rating and sizable gap to the stated target are bullish, though analyst targets are opinions and do not guarantee performance.
What happened, with direct paths to the underlying reporting
Needham reiterated its Buy rating on KIDS with a $35 target versus a posted price of $23.82, implying substantial indicated upside.
Target: $35
Posted price: $23.82
Analyst firm: Needham
Analyst: Mike Matson
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.